American Society of Addiction Medicine
American Society of Addiction Medicine
Lead: Machine learning– and multilayer molecular network–assisted screening hunts fentanyl compound
Lead: Machine learning– and multilayer molecular network–assisted screening hunts fentanyl compound
Lead: Machine learning– and multilayer molecular network–assisted screening hunts fentanyl compound
Tuesday 16th September 2025
Explore cutting-edge research in addiction medicine, from fentanyl detection to telehealth treatment and the power of language in recovery.
8 minutes
Informative
Inspiring
Educational
Supportive
Eye-opening
About this podcast
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Episodes:
179 (View all)
Do you want to link to this podcast?
Get the buttons here!Uncovering Innovations in Addiction Medicine: From Fentanyl Screening to Stigma-Free Care
Episode Overview
- Fentanyl-Hunter uses machine learning to detect fentanyl compounds effectively.
- Increased risk of congenital heart disease found in newborns with neonatal abstinence syndrome.
- Combination therapy with methadone and slow-release oral morphine shows promise.
- Telehealth offers a cost-effective alternative for opioid use disorder treatment.
- Person-first language is crucial in reducing stigma in addiction care.
"Language matters, and the words we use can have a profound impact on those in recovery."
In this eye-opening episode of 'This Week in Addiction Medicine', listeners are taken on a journey through the latest developments in addiction research and treatment. Hosted by Zach Caruso, the episode kicks off with a discussion on Fentanyl-Hunter, a cutting-edge screening platform that uses machine learning to identify fentanyl compounds. This innovative tool has the potential to revolutionise how we detect and manage fentanyl presence in various environments.
The episode then shifts gears to explore the connection between neonatal abstinence syndrome and congenital heart disease, highlighting the increased risk for newborns exposed to opioids. As the conversation unfolds, listeners are introduced to a study from Ontario examining methadone dosing patterns and the impact of combination therapy with slow-release oral morphine. The findings suggest new approaches could enhance treatment outcomes for those battling opioid use disorder.
Next up is a comparison between telehealth and in-person buprenorphine treatment for opioid use disorder, revealing telehealth as a cost-effective alternative, albeit with some differences in retention rates. The podcast also touches on paternal alcohol consumption's impact on fetal alcohol spectrum disorders, suggesting that both maternal and paternal drinking patterns play a role in child outcomes.
Wrapping up the episode, listeners are presented with insights into stigmatizing language used in addiction care, emphasising the importance of person-first language in fostering a supportive environment for recovery. With its mix of scientific research and human stories, this episode provides a comprehensive look at the challenges and innovations in addiction medicine today. Ready to be informed and inspired? Tune in to learn how cutting-edge research is shaping the future of addiction treatment.